Received: 13 April 2022
Accepted: 29 November 2022
First Online: 14 December 2022
: This study is conducted in compliance with the Helsinki Declaration and the Clinical Trial Act by the Japanese government. It has been approved by the Certified Review Board, the ethics committee of Nara Medical University (CRB 5200002). All participants gave informed consent following a full explanation of the aim of the study, the process of the study, advantages, disadvantages, potential risks/benefits of taking part, and their freedom to withdraw from the study at any stage, without any penalty. We anonymized all findings at all stages of the study and kept confidential all information sources by removing all participant’s identifiers and keeping data in a locked cabinet. We present the quotes, which illustrate the results after removing the names using a code comprising used data collection mean, type of participant, and participant’s order number.
: Not applicable.
: The authors declare that they have no competing interests.